✦ LIBER ✦

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease

✍ Scribed by M. J. SHALE; C. H. SEOW; C. S. COFFIN; G. G. KAPLAN; R. PANACCIONE; S. GHOSH

Book ID: 108605734
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 121 KB
Volume: 31
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2009.04112.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review article: use of antitumour necros

Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception

✍ S. O'DONNELL; C. O'MORAIN 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

European guidelines for the use of anti-

European guidelines for the use of anti-tumour necrosis factor agents in inflammatory bowel disease

✍ Wolfgang Kruis 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 13 KB

Review article: the effects of antitumou

Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease

✍ S. G. Veerappan; C. A. O’Morain; J. S. Daly; B. M. Ryan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Psoriasis associated with anti-tumour ne

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature

✍ G. Cullen; D. Kroshinsky; A. S. Cheifetz; J. R. Korzenik 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

The safety profile of anti-tumour necros

The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up

✍ C. W. LEES; A. I. ALI; A. I. THOMPSON; G.-T. HO; R. O. FORSYTHE; L. MARQUEZ; C. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Differences in the incidence of flares o

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents

✍ Braun, J. ;Baraliakos, X. ;Listing, J. ;Davis, J. ;van der Heijde, D. ;Haibel, H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Objective Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are clinically and pathologically linked. Anti–tumor necrosis factor (anti‐TNF) agents are efficacious in treating AS, but not all are equally effective in treating IBD (Crohn's disease [CD] and ulcerative co